NEW YORK (Reuters) – The sound start for U.S. health insurer shares this year may guise into a long climb.
Shunned like pariahs during the economic conjuncture and healthcare reform debate, the stocks have caught fire, with the Morgan Stanley Healthcare Payor table of contents of large and small insurers up more than 16 percent such far in 2011 compared with a 5 percent rise for the broader S&P 500 fore-finger.
Many investors have already accounted for the potential near-term costs of a U.S. freedom from disease overhaul law passed last year and its impact on the results’s bottom line. Some of that impact may even exist delayed by efforts to undermine the law from a new Republican predominance in the House of Representatives and by legal challenges in court.
Companies like Aetna Inc and UnitedHealth Group Inc well-informed strong financial results in 2010 and provided reassuring forecasts for 2011, at what time rules from the new law begin that require certain levels of expenditure on medical costs.
They could also benefit if Americans remain wary about their own healthcare spending and an anticipated rise in curative procedures fails to materialize.
Portfolio managers who shied away from the shares during the health reform debate are now seeing deep value.
U.S. and adventitious mutual funds added more than billion of health insurance stocks to their portfolios adhering a net basis at the end of the year, according to novel data compiled by Thomson Reuters.
Even with their recent run, the public securities still trade at about a 20 percent discount to the broader mart.
“Fundamentally I think they’re going to have a self-same good 2011 earnings season. I think they’re under-owned, and I believe the political environment is probably more favorable for them now than it has been since a while,” said David Heupel, portfolio manager with Thrivent Investment Management, that holds shares of Aetna.
Aetna, which recently issued a far stronger-than-expected forecast and substantially raised its dividend, has seen its shares climb 23 percent this year. UnitedHealth and WellPoint Inc, the two biggest insurers, are up 18 percent and 15 percent, respectively.
Shares of Cigna Corp, Humana Inc and Coventry Health Care Inc be delivered of also outpaced the broader market in 2011.
Heupel sees the potential for the stocks in general to rise another 15 percent to 20 percent this year, in function driven by broader generalist investors becoming more interested in the arrange.
“A lot of folks, as they’re scouring their universes, are looking at these things and they’re expression: ‘Now that all this healthcare reform carnage is over, or at least is better understood, we can now begin to gauge how beneficial these companies will be,’” said Scott Richter, who oversees the Fifth Third Disciplined Large Cap Value Fund.
“I indeed do feel the fundamental picture is as strong as it’s been in separate years and that’s going to propel investors, especially esteem investors, toward these stocks.”
BOOST AT THE DOCTOR’S OFFICE?
No comments:
Post a Comment